Loading the company…
Loading the company…
In the last ten years FDA made 1 decision for Urgo Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2026 (1). The latest was on 2026-08-11.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-08-11 | 510(k) | K253665 | Vashe Plus Antimicrobial Solution |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Urgo Medical.
In 2025, Urgo Medical reported engagement with 2,661 surgeons and other clinicians in the states MedaRep covers, worth $214K in consulting, speaking, meals and travel for its device products, the most in California ($21K to 274). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($21K, 274 engaged), Arizona ($21K, 59 engaged), Michigan ($15K, 158 engaged), Montana ($15K, 2 engaged), Texas ($14K, 249 engaged).